Regeneron Pharmaceuticals (REGN) Debt Ratio (2020 - 2026)

Regeneron Pharmaceuticals has reported Debt Ratio for 7 years, with the latest figure at 0.05 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 8.07% year-over-year to 0.05; the trailing twelve-month figure through Mar 2026 stood at 0.05 (down 8.07% YoY), and the FY2025 full-year result was 0.05, down 6.83% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.05, down from 0.05 in the prior quarter.
• The five-year high for Debt Ratio was 0.08 in Q1 2022, with the low at 0.05 in Q1 2026.
• Average Debt Ratio over 5 years is 0.06, with a median of 0.06 recorded in 2024.
• Year-over-year, Debt Ratio tumbled 32.5% in 2022 and retreated 5.51% in 2025.
• Tracing REGN's Debt Ratio over 5 years: stood at 0.07 in 2022, then slipped by 11.62% to 0.06 in 2023, then decreased by 12.33% to 0.05 in 2024, then retreated by 6.83% to 0.05 in 2025, then dropped by 0.75% to 0.05 in 2026.
• The last three Debt Ratio figures came in at 0.05 (Q1 2026), 0.05 (Q4 2025), and 0.05 (Q3 2025), per Business Quant data.

Peer Comparison